-
Mashup Score: 1Agenda Details | ASGCT 25th Annual Meeting - 2 year(s) ago
Detailed Program …
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Agenda Details | ASGCT 25th Annual Meeting - 2 year(s) ago
Wednesday, May 18 2022 08:50 AM – 09:15 AM ET. Breaking Down Gene Therapy and CRISPR Topics for Non-scientific Audiences Jennifer E. Adair, PhD. Fred Hutch, Seattle, WA …
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Agenda Details | ASGCT 25th Annual Meeting - 2 year(s) ago
Wednesday, May 18 2022 08:00 AM – 09:45 AM ET. Challenges and Status in Development of Gene Therapies in LMICs (Organized by the Global Outreach Committee) This symposium will highlight the barriers to the development of gene therapies in…
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Agenda Details | ASGCT 25th Annual Meeting - 2 year(s) ago
Monday, May 16 2022 04:45 PM – 05:00 PM ET. Preclinical Development of Safe and Effective T Cell Receptors Specific for Mutant KRAS G12V and G12D Peptides Tijana Martinov{1}, Rachel Perret{1,2}, Shwetha Mureli{1}, Clara McCurdy{1}, Angie…
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Home | ASGCT 25th Annual Meeting - 2 year(s) ago
The Annual Meeting will be a hybrid event in 2022! Walter E. Washington Convention Center 801 Mt Vernon Pl NW Washington, D.C. Learn About the Annual Meeting …
Source: annualmeeting.asgct.orgCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 2Home | ASGCT 25th Annual Meeting - 2 year(s) ago
The Annual Meeting will be a hybrid event in 2022! Walter E. Washington Convention Center 801 Mt Vernon Pl NW Washington, D.C. Learn About the Annual Meeting …
Source: annualmeeting.asgct.orgCategories: Latest Headlines, Rare DiseaseTweet
-
Mashup Score: 1Abstract Details | ASGCT 25th Annual Meeting - 2 year(s) ago
I – Gene & Cell Therapy Trials in Progress -> Gene & Cell Therapy Trials in Progress 793: A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus Vulgaris (mPV) Patients: Early Cohort Data Type: Poster Session …
Source: annualmeeting.asgct.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Registration | ASGCT 24th Annual Meeting | American Society of Gene & Cell Therapy | - 3 year(s) ago
Registration is Now Open! Register now for the 24th Annual Meeting! Please note: ASGCT Associate Members can now register for the meeting for free! There are two ways you can register, depending on the size of your group: Individual registration: This option is meant for ASGCT Members and nonmembers. Group registration: This option is meant for five or…
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration | ASGCT 24th Annual Meeting | American Society of Gene & Cell Therapy | - 3 year(s) ago
Registration is Now Open! Register now for the 24th Annual Meeting! Please note: ASGCT Associate Members can now register for the meeting for free! There are two ways you can register, depending on the size of your group: Individual registration: This option is meant for ASGCT Members and nonmembers. Group registration: This option is meant for five or…
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration | ASGCT 24th Annual Meeting | American Society of Gene & Cell Therapy | - 3 year(s) ago
Registration is Now Open! Register now for the 24th Annual Meeting! Please note: ASGCT Associate Members can now register for the meeting for free! There are two ways you can register, depending on the size of your group: Individual registration: This option is meant for ASGCT Members and nonmembers. Group registration: This option is meant for five or…
Source: annualmeeting.asgct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Fred Hutch at #ASGCT22 | Stefan Radtke - 808: Short- and Long-Term Hematopoietic Reconstitution After Transplantation is Stem CellDriven and Stochastic: Implications for Gene Therapy 🗓️ Wednesday, May 18, 2:15 p.m. ET | Hall E https://t.co/skaDSZSZkY https://t.co/NyNxEgDY0W